Pharmaceutical Synthesis: The Value of 4,7-Dibromo-5,6-dinitro-2,1,3-benzothiadiazole
In the complex world of pharmaceutical synthesis, the availability of high-quality building blocks is essential for developing new and effective therapeutics. 4,7-Dibromo-5,6-dinitro-2,1,3-benzothiadiazole (CAS 76186-72-6), a compound known for its potential in organic chemistry, stands out as a valuable pharmaceutical intermediate. For R&D scientists and procurement teams, understanding its properties and sourcing options is key.
This specific benzothiadiazole derivative, with a purity of 98%, offers a unique chemical structure that can be leveraged in the synthesis of Active Pharmaceutical Ingredients (APIs). Researchers looking to buy this compound for their drug discovery programs will find its specific molecular formula (C6Br2N4O4S) and weight (383.96 g/mol) crucial for reaction planning and optimization. Its role as an intermediate means it facilitates the creation of more complex therapeutic molecules.
When considering the purchase of pharmaceutical intermediates, the reliability of the manufacturer is paramount. Companies in the pharmaceutical sector often work with established chemical suppliers, particularly those in China, who are equipped for large-scale production and stringent quality control. This ensures that the intermediate meets the demanding standards of pharmaceutical research and manufacturing. Enquiring about the price from direct manufacturers can offer significant cost advantages.
The importance of a stable supply chain for CAS 76186-72-6 cannot be overstated. Pharmaceutical development timelines are often tight, and delays due to ingredient shortages can be costly. Partnering with a reputable supplier who guarantees consistent availability and timely delivery is a critical aspect of successful drug development. This allows research teams to focus on their scientific endeavors rather than supply chain concerns.
For any organization involved in pharmaceutical synthesis and requiring 4,7-Dibromo-5,6-dinitro-2,1,3-benzothiadiazole, seeking out a dedicated manufacturer and supplier is a prudent step. Their expertise in chemical production, coupled with competitive pricing and a commitment to quality, can be instrumental in advancing your pharmaceutical projects.
Perspectives & Insights
Bio Analyst 88
“4,7-Dibromo-5,6-dinitro-2,1,3-benzothiadiazole (CAS 76186-72-6), a compound known for its potential in organic chemistry, stands out as a valuable pharmaceutical intermediate.”
Nano Seeker Pro
“For R&D scientists and procurement teams, understanding its properties and sourcing options is key.”
Data Reader 7
“This specific benzothiadiazole derivative, with a purity of 98%, offers a unique chemical structure that can be leveraged in the synthesis of Active Pharmaceutical Ingredients (APIs).”